CHAPEL HILL, N.C., May 27 /PRNewswire/ -- Health outcomes data can be an important promotional/commercial tool for the biopharmaindustry, but approaches differ company to company as the marketplace continues to evolve. A new study by Best Practices, LLC examines internal and external uses of health outcomes data for promotional purposes.
The study found while a majority
These insights represent just a small portion of the metric-driven data available in Best Practices in Utilizing Health Outcomes Data for Promotional/Commercial Efforts, new research that seeks to understand how pharmaceutical and biotech organizations use health outcomes data in promotional settings. The study also examined the pressing Regulatory issues raised by the different uses of health outcomes data.
Key topics covered in this research include:
To learn more about this report, including information about the research participants, key findings and sample best practices, please download a complimentary excerpt and study overview at: http://www3.best-in-class.com/rr1000.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies. For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All